PMID- 38517943 OWN - NLM STAT- Publisher LR - 20240322 IS - 2042-7158 (Electronic) IS - 0022-3573 (Linking) DP - 2024 Mar 22 TI - Integrating metabolomics and network pharmacology to assess the effects of Mahuang Xixin Fuzi decoction on migraine rats induced by nitroglycerin. LID - rgae025 [pii] LID - 10.1093/jpp/rgae025 [doi] AB - OBJECTIVES: This study was designed to investigate the pharmacological activity and therapeutic mechanism of Mahuang Xixin Fuzi decoction (MXFD) on migraine. METHODS: Migraine model rats induced by nitroglycerin were established, and then orally administered with MXFD for 7 days. Blood and urine samples were collected to identify differential metabolites with metabolomics. To integrate the findings from network pharmacology and metabolomics analysis, the metabolites and targets related to MXFD therapy for migraine were filtered. KEY FINDINGS: MXFD was found to alleviate the symptoms of migraines in rats. After treatment with MXFD, nine metabolites were found to be regulated and returned to normal levels. MXFD acted directly on nine key targets including MAOB, MAOA, ADRB1, ADRB2, ADRB3, ADORA2A, ADORA2B, DRD5, and HTR4 and regulated two out of nine metabolites, namely deoxycholic acid and 5-methoxyindoleacetate. CONCLUSIONS: The study found that MXFD can alleviate migraines through multitarget and multicomponent interaction networks. CI - (c) The Author(s) 2024. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. FAU - Ge, Fei AU - Ge F AUID- ORCID: 0000-0001-8458-1401 AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Zhang, Yao AU - Zhang Y AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Luo, Yamin AU - Luo Y AD - Bejing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Wang, Chunguo AU - Wang C AD - Bejing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Lu, Yixing AU - Lu Y AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Zhao, Yafang AU - Zhao Y AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Zhang, Di AU - Zhang D AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Meng, Fengxian AU - Meng F AD - Dongfang Hospital of Beijing University of Traditional Chinese Medicine, 100078 Beijing, China. FAU - Zhang, Dongmei AU - Zhang D AD - Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, 101121 Beijing, China. FAU - Chen, Meng AU - Chen M AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. FAU - Tao, Xiaohua AU - Tao X AD - College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, 100029 Beijing, China. AD - Research Institute of Chinese Medicine Literature, Beijing University of Chinese Medicine, 100029 Beijing, China. LA - eng GR - 81974542/National Natural Science Foundation of China/ PT - Journal Article DEP - 20240322 PL - England TA - J Pharm Pharmacol JT - The Journal of pharmacy and pharmacology JID - 0376363 SB - IM OTO - NOTNLM OT - Mahuang-Xixin-Fuzi decoction OT - metabolomics OT - migraine OT - network pharmacology EDAT- 2024/03/22 18:44 MHDA- 2024/03/22 18:44 CRDT- 2024/03/22 13:53 PHST- 2023/10/23 00:00 [received] PHST- 2024/02/24 00:00 [accepted] PHST- 2024/03/22 18:44 [medline] PHST- 2024/03/22 18:44 [pubmed] PHST- 2024/03/22 13:53 [entrez] AID - 7633714 [pii] AID - 10.1093/jpp/rgae025 [doi] PST - aheadofprint SO - J Pharm Pharmacol. 2024 Mar 22:rgae025. doi: 10.1093/jpp/rgae025.